That scale means even an unexpected benefit, or an unexpected harm, becomes a public health event
As of July 2026, retatrutide is not FDA approved for any indication, and no application has been filed yet
Lawyers are reviewing medical records to identify consistent patterns in drug usage, such as dosage escalation and combination with other GLP-1 medications
Quick Comparison Table This table summarizes the differences, but the real story requires understanding how each medication works at the mechanism level
Joshua Silva, MD Nov 19, 2025 5 min read If youre comparing Zepbound (tirzepatide, GLP-1/GIP) vs
Myles Keroack is board-certified in gastroenterology and is accepting new patients at Elliot Gastroenterology.